InvestorsHub Logo
Followers 472
Posts 37018
Boards Moderated 0
Alias Born 01/11/2004

Re: Skiluc post# 70068

Wednesday, 06/30/2021 9:59:06 AM

Wednesday, June 30, 2021 9:59:06 AM

Post# of 118379
...establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug delivery systems in the treatment of various disorders including human pancreatic cancer and colon cancer.

Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase

https://www.biospace.com/article/releases/oncology-pharma-inc-is-entering-into-the-next-phase-of-its-growth-and-expansion-phase/